AF
ONCR

Amalgamated Financial’s Oncorus, Inc. ONCR Stock Holding History

Amalgamated Financial’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$4K Buy
+2,459
New +$6.89K ﹤0.01% 2976

Other funds holding ONCR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Amalgamated Financial's ONCR Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Oncorus, Inc. (ONCR) in Q1 2022: 2,459 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #2976 among its holdings.

56 funds tracked by Wall St. Rank hold ONCR as of Q1 2022.

  • Amalgamated Financial held 2,459 shares of Oncorus, Inc. worth $4K as of Q1 2022.
  • Oncorus, Inc. was a new Amalgamated Financial position in Q1 2022.
  • Oncorus, Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2976 holding.
  • 56 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.